Literature DB >> 17846973

Emerging role of SUMO in pancreatic beta-cells.

A Ehninger1, H Mziaut, M Solimena.   

Abstract

Post-translational attachment of small ubiquitin-like modifier (SUMO), defined as SUMOylation, can affect the localization, interactions, stability and/or activity of substrate proteins, and thus can participate in a large variety of cellular processes. Most SUMO substrates are involved in transcriptional regulation. Hence, SUMOylation can either activate or, more commonly, repress gene transcription. The modulation of gene expression by SUMO through diverse mechanisms and specifically the recent findings concerning SUMOylation in pancreatic beta-cells are reviewed.

Mesh:

Substances:

Year:  2007        PMID: 17846973     DOI: 10.1055/s-2007-985372

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

Review 1.  Unraveling pancreatic islet biology by quantitative proteomics.

Authors:  Jian-Ying Zhou; Geoffrey P Dann; Chong Wee Liew; Richard D Smith; Rohit N Kulkarni; Wei-Jun Qian
Journal:  Expert Rev Proteomics       Date:  2011-08       Impact factor: 3.940

2.  Epigenetics of diabetic complications.

Authors:  Louisa M Villeneuve; Rama Natarajan
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

Review 3.  Underappreciated roles for Rho GDP dissociation inhibitors (RhoGDIs) in cell function: Lessons learned from the pancreatic islet β-cell.

Authors:  Anjaneyulu Kowluru; Noah F Gleason
Journal:  Biochem Pharmacol       Date:  2021-12-28       Impact factor: 5.858

4.  SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.

Authors:  Xiao-Qing Dai; Greg Plummer; Marina Casimir; Youhou Kang; Catherine Hajmrle; Herbert Y Gaisano; Jocelyn E Manning Fox; Patrick E MacDonald
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

5.  Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets.

Authors:  Safia Costes; Brigitte Vandewalle; Cécile Tourrel-Cuzin; Christophe Broca; Nathalie Linck; Gyslaine Bertrand; Julie Kerr-Conte; Bernard Portha; François Pattou; Joel Bockaert; Stéphane Dalle
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

6.  DeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals.

Authors:  Elisa Vergari; Gregory Plummer; Xiaoqing Dai; Patrick E MacDonald
Journal:  Biomolecules       Date:  2012-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.